Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiro Oka

Showing results (451-460 of 477) with videos related to

Pageof 48
Sort By:
International Journal of Clinical Oncology|November 4, 2025
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancerYusuke Kinugasa, Kay Uehara, Kensei Yamaguchi, et al.
Cancers|October 27, 2022
Analysis of Lenvatinib's Efficacy against Intermediate-Stage Unresectable Hepatocellular CarcinomaKei Amioka, Tomokazu Kawaoka, Takahiro Kinami, et al.
Annals of Surgery|September 5, 2023
How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-risk T1 Colorectal Cancer?Akira Ouchi, Koji Komori, Tajika Masahiro, et al.
Liver Cancer|January 29, 2026
Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective StudyKo Hashimoto, Tomokazu Kawaoka, Tomoaki Emori, et al.
Investigational New Drugs|June 6, 2024
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)Kazufumi Kobayashi, Sadahisa Ogasawara, Ei Itobayashi, et al.
International Journal of Clinical Oncology|June 17, 2019
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancerYojiro Hashiguchi, Kei Muro, Yutaka Saito, et al.
BMC Gastroenterology|February 8, 2024
Efficacy of endoscopic submucosal resection with a ligation device for small rectal neuroendocrine tumor: study protocol of a multicenter open-label randomized control trial (BANDIT trial)Kazunori Takada, Kenichiro Imai, Takanori Yamada, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|April 1, 2018
Validation study for development of the Japan NBI Expert Team classification of colorectal lesionsMineo Iwatate, Yasushi Sano, Shinji Tanaka, et al.
The American Journal of Gastroenterology|February 12, 2024
Treatment Decision for Locally Resected T1 Colorectal Carcinoma-Verification of the Japanese Guideline Criteria for Additional Surgery Based on Long-Term Clinical OutcomesShiro Oka, Shinji Tanaka, Yoshiki Kajiwara, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|March 2, 2016
Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert TeamYasushi Sano, Shinji Tanaka, Shin-Ei Kudo, et al.
Pageof 48

Showing results (451-460 of 477) with videos related to

Sort By:
Pageof 48
International Journal of Clinical Oncology|November 4, 2025
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancerYusuke Kinugasa, Kay Uehara, Kensei Yamaguchi, et al.
Cancers|October 27, 2022
Analysis of Lenvatinib's Efficacy against Intermediate-Stage Unresectable Hepatocellular CarcinomaKei Amioka, Tomokazu Kawaoka, Takahiro Kinami, et al.
Annals of Surgery|September 5, 2023
How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-risk T1 Colorectal Cancer?Akira Ouchi, Koji Komori, Tajika Masahiro, et al.
Liver Cancer|January 29, 2026
Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective StudyKo Hashimoto, Tomokazu Kawaoka, Tomoaki Emori, et al.
Investigational New Drugs|June 6, 2024
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)Kazufumi Kobayashi, Sadahisa Ogasawara, Ei Itobayashi, et al.
International Journal of Clinical Oncology|June 17, 2019
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancerYojiro Hashiguchi, Kei Muro, Yutaka Saito, et al.
BMC Gastroenterology|February 8, 2024
Efficacy of endoscopic submucosal resection with a ligation device for small rectal neuroendocrine tumor: study protocol of a multicenter open-label randomized control trial (BANDIT trial)Kazunori Takada, Kenichiro Imai, Takanori Yamada, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|April 1, 2018
Validation study for development of the Japan NBI Expert Team classification of colorectal lesionsMineo Iwatate, Yasushi Sano, Shinji Tanaka, et al.
The American Journal of Gastroenterology|February 12, 2024
Treatment Decision for Locally Resected T1 Colorectal Carcinoma-Verification of the Japanese Guideline Criteria for Additional Surgery Based on Long-Term Clinical OutcomesShiro Oka, Shinji Tanaka, Yoshiki Kajiwara, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|March 2, 2016
Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert TeamYasushi Sano, Shinji Tanaka, Shin-Ei Kudo, et al.
Pageof 48